SU6656, a Selective Src Family Kinase Inhibitor, Used To Probe Growth Factor Signaling

REFERENCES

• Barone, M. V., and Courtneidge, S. A.. 1995. Myc but not Fos rescue of PDGF signalling block caused by kinase inactive Src. Nature 378:509–512
   PubMed Web of Science ®Google Scholar
• Blake, R. A., Garcia-Paramio, P., Parker, P. J., and Courtneidge, S. A.. 1999. Src promotes PKCdelta degradation. Cell Growth Differ. 10:231–241
   PubMedGoogle Scholar
• Broome, M. A., and Courtneidge, S. A.. 2000. No requirement for src family kinases for PDGF signaling in fibroblasts expressing SV40 large T antigen. Oncogene 19:2867–2869
   PubMed Web of Science ®Google Scholar
• Broome, M. A., Galisteo, M. L., Schlessinger, J., and Courtneidge, S. A.. 1999. The proto-oncogene c-Cbl is a negative regulator of DNA synthesis initiated by both receptor and cytoplasmic tyrosine kinases. Oncogene 18:2908–2912
   PubMedGoogle Scholar
• Cardenas, M. E., Sanfridson, A., Cutler, N. S., and Heitman, J.. 1998. Signal-transduction cascades as targets for therapeutic intervention by natural products. Trends Biotechnol. 16:427–433
   PubMed Web of Science ®Google Scholar
• DeMali, K. A., and Kazlauskas, A.. 1998. Activation of Src family members is not required for the platelet-derived growth factor beta receptor to initiate mitogenesis. Mol. Cell. Biol. 18:2014–2022
   PubMedGoogle Scholar
• Goekjian, P. G., and Jirousek, M. R.. 1999. Protein kinase C in the treatment of disease: signal transduction pathways, inhibitors, and agents in development. Curr. Med. Chem. 6:877–903
   PubMed Web of Science ®Google Scholar
• Gotoh, N., Toyoda, M., and Shibuya, M.. 1997. Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation. Mol. Cell. Biol. 17:1824–1831
   PubMed Web of Science ®Google Scholar
• Heldin, C. H., Ostman, A., and Ronnstrand, L.. 1998. Signal transduction via platelet-derived growth factor receptors. Biochim. Biophys. Acta 1378:F79–F113
   PubMed Web of Science ®Google Scholar
• Hill, R. J., Zozulya, S., Lu, Y. L., Hollenbach, P. W., Joyce-Shaikh, B., Bogenberger, J., and Gishizky, M. L.. 1996. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein. Cell Growth Differ. 7:1125–1134
   PubMedGoogle Scholar
• Joazeiro, C. A., Wing, S. S., Huang, H., Leverson, J. D., Hunter, T., and Liu, Y. C.. 1999. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286:309–312
   PubMed Web of Science ®Google Scholar
• Klinghoffer, R. A., Sachsenmaier, C., Cooper, J. A., and Soriano, P.. 1999. Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J. 18:2459–2471
   PubMed Web of Science ®Google Scholar
• Koegl, M., Kypta, R., Bergman, M., Alitalo, K., and Courtneidge, S.. 1994. Rapid and efficient purification of Src homology 2 domain-containing proteins: Fyn, Csk and phosphatidylinositol 3-kinase p85. Biochem. J. 302:737–744
   PubMedGoogle Scholar
• Kypta, R. M., Goldberg, Y., Ulug, E. T., and Courtneidge, S. A.. 1990. Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell 62:481–492
   PubMed Web of Science ®Google Scholar
• Lee, J. C., and Adams, J. L.. 1995. Inhibitors of serine/threonine kinases. Curr. Opin. Biotechnol. 6:657–661
   PubMedGoogle Scholar
• Levkowitz, G., Waterman, H., Ettenberg, S. A., Katz, M., Tsygankov, A. Y., Alroy, I., Lavi, S., Iwai, K., Reiss, Y., Ciechanover, A., Lipkowitz, S., and Yarden, Y.. 1999. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol. Cell 4:1029–1040
   PubMed Web of Science ®Google Scholar
• Luttrell, L. M., Della Rocca, G. J., van Biesen, T., Luttrell, D. K., and Lefkowitz, R. J.. 1997. Gbetagamma subunits mediate Src-dependent phosphorylation of the epidermal growth factor receptor. A scaffold for G protein-coupled receptor-mediated Ras activation. J. Biol. Chem. 272:4637–4644
   PubMedGoogle Scholar
• Luttrell, L. M., Hawes, B. E., van Biesen, T., Luttrell, D. K., Lansing, T. J., and Lefkowitz, R. J.. 1996. Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases. J. Biol. Chem. 271:19443–19450
   PubMed Web of Science ®Google Scholar
• Marrero, M. B., Schieffer, B., Paxton, W. G., Schieffer, E., and Bernstein, K. E.. 1995. Electroporation of pp60c-src antibodies inhibits the angiotensin II activation of phospholipase C-gamma 1 in rat aortic smooth muscle cells. J. Biol. Chem. 270:15734–15738
   PubMed Web of Science ®Google Scholar
• McGlade, J., Cheng, A., Pelicci, G., Pelicci, P. G., and Pawson, T.. 1992. Shc proteins are phosphorylated and regulated by the v-Src and v-Fps protein-tyrosine kinases. Proc. Natl. Acad. Sci. USA 89:8869–8873
   PubMedGoogle Scholar
• Mischak, H., Goodnight, J. A., Kolch, W., Martiny-Baron, G., Schaechtle, C., Kazanietz, M. G., Blumberg, P. M., Pierce, J. H., and Mushinski, J. F.. 1993. Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. J. Biol. Chem. 268:6090–6096
   PubMed Web of Science ®Google Scholar
• Mishima, K., Ohno, S., Shitara, N., Yamaoka, K., and Suzuki, K.. 1994. Opposite effects of the overexpression of protein kinase C gamma and delta on the growth properties of human glioma cell line U251 MG. Biochem. Biophys. Res. Commun. 201:363–372
   PubMedGoogle Scholar
• Parker, P. J.. 1999. Inhibition of protein kinase C—do we, can we, and should we? Pharmacol. Ther. 82:263–267
   PubMedGoogle Scholar
• Roche, S., Koegl, M., Barone, M. V., Roussel, M. F., and Courtneidge, S. A.. 1995. DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases. Mol. Cell. Biol. 15:1102–1109
   PubMed Web of Science ®Google Scholar
• Roche, S., McGlade, J., Jones, M., Gish, G. D., Pawson, T., and Courtneidge, S. A.. 1996. Requirement of phospholipase Cγ, the tyrosine phosphatase Syp and the adaptor proteins Shc and Nck for PDGF-induced DNA synthesis: evidence for the existence of Ras-dependent and Ras-independent pathways. EMBO J. 15:4940–4948
   PubMedGoogle Scholar
• Salcini, A. E., McGlade, J., Pelicci, G., Nicoletti, I., Pawson, T., and Pelicci, P. G.. 1994. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene 9:2827–2836
   PubMedGoogle Scholar
• Sato, K., Gotoh, N., Otsuki, T., Kakumoto, M., Aoto, M., Tokmakov, A. A., Shibuya, M., and Fukami, Y.. 1997. Tyrosine residues 239 and 240 of Shc are phosphatidylinositol 4,5-bisphosphate-dependent phosphorylation sites by c-Src. Biochem. Biophys. Res. Commun. 240:399–404
   PubMedGoogle Scholar
• Sato, K., Yamamoto, H., Otsuki, T., Aoto, M., Tokmakov, A. A., Hayashi, F., and Fukami, Y.. 1997. Phosphatidylinositol 4,5-bisphosphate stimulates phosphorylation of the adaptor protein Shc by c-Src. FEBS Lett. 410:136–140
   PubMedGoogle Scholar
• Sun, L., Tran, N., Liang, C., Tang, F., Rice, A., Schreck, R., Waltz, K., Shawver, L. K., McMahon, G., and Tang, C.. 1999. Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl) methylindenyl]indolin-2-ones as inhibitors of VEGF, PDGF, and FGF receptor tyrosine kinases. J. Med. Chem. 42:5120–5130
   PubMed Web of Science ®Google Scholar
• Sun, L., Tran, N., Tang, T., App, H., Hirth, P., McMahon, G., and Tang, C.. 1998. Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases. J. Med. Chem. 41:2588–2603
   PubMed Web of Science ®Google Scholar
• Twamley-Stein, G. M., Pepperkok, R., Ansorge, W., and Courtneidge, S. A.. 1993. The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 90:7696–7700
   PubMed Web of Science ®Google Scholar
• van der Geer, P., Wiley, S., Gish, G. D., and Pawson, T.. 1996. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions. Curr. Biol. 6:1435–1444
   PubMed Web of Science ®Google Scholar
• Waltenberger, J., Uecker, A., Kroll, J., Frank, H., Mayr, U., Bjorge, J. D., Fujita, D., Gazit, A., Hombach, V., Levitzki, A., and Bohmer, F. D.. 1999. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling. Circ. Res. 85:12–22
   PubMedGoogle Scholar
• Wang, H. C., and Erikson, R. L.. 1992. Activation of protein serine/threonine kinases p42, p63, and p87 in Rous sarcoma virus-transformed cells: signal transduction/transformation-dependent MBP kinases. Mol. Biol. Cell 3:1329–1337
   PubMedGoogle Scholar
• Watanabe, T., Ono, Y., Taniyama, Y., Hazama, K., Igarashi, K., Ogita, K., Kikkawa, U., and Nishizuka, Y.. 1992. Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies. Proc. Natl. Acad. Sci. USA 89:10159–10163
   PubMed Web of Science ®Google Scholar